JP2023535842A5 - - Google Patents

Info

Publication number
JP2023535842A5
JP2023535842A5 JP2023507231A JP2023507231A JP2023535842A5 JP 2023535842 A5 JP2023535842 A5 JP 2023535842A5 JP 2023507231 A JP2023507231 A JP 2023507231A JP 2023507231 A JP2023507231 A JP 2023507231A JP 2023535842 A5 JP2023535842 A5 JP 2023535842A5
Authority
JP
Japan
Prior art keywords
domain
composition according
modified
wild
human igg1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023507231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535842A (ja
Filing date
Publication date
Priority claimed from FR2008211A external-priority patent/FR3112939B1/fr
Application filed filed Critical
Publication of JP2023535842A publication Critical patent/JP2023535842A/ja
Publication of JP2023535842A5 publication Critical patent/JP2023535842A5/ja
Pending legal-status Critical Current

Links

JP2023507231A 2020-07-31 2021-08-02 普遍的な細胞療法のための武装ｎｋ細胞 Pending JP2023535842A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR2008211A FR3112939B1 (fr) 2020-07-31 2020-07-31 Produit universel de thérapie cellulaire et son utilisation
FR2008211 2020-07-31
PCT/EP2021/071586 WO2022023581A1 (en) 2020-07-31 2021-08-02 Armed nk cells for universal cell therapy

Publications (2)

Publication Number Publication Date
JP2023535842A JP2023535842A (ja) 2023-08-21
JP2023535842A5 true JP2023535842A5 (https=) 2024-08-08

Family

ID=74095859

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507231A Pending JP2023535842A (ja) 2020-07-31 2021-08-02 普遍的な細胞療法のための武装ｎｋ細胞

Country Status (9)

Country Link
US (1) US20240293455A1 (https=)
EP (1) EP4188396A1 (https=)
JP (1) JP2023535842A (https=)
KR (1) KR20230078632A (https=)
CN (1) CN116744946A (https=)
AU (1) AU2021316729A1 (https=)
CA (1) CA3189963A1 (https=)
FR (1) FR3112939B1 (https=)
WO (1) WO2022023581A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115369086B (zh) * 2022-02-22 2023-05-12 北京景达生物科技有限公司 一种nk细胞扩大培养的培养方案
EP4729126A1 (en) 2024-10-17 2026-04-22 Centre National de la Recherche Scientifique Nk cell-derived extracellular vesicles armed with modified monoclonal antibodies to target cancer cells, and use thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US64413A (en) 1867-05-07 Improvement in wagon-beake
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
MX9203291A (es) 1985-06-26 1992-08-01 Liposome Co Inc Metodo para acoplamiento de liposomas.
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
AU1908395A (en) 1994-01-28 1995-08-15 Board Of Trustees Of The Leland Stanford Junior University Antibodies to mammalian natural killer antigens and uses
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
FR2915398B1 (fr) * 2007-04-25 2012-12-28 Lab Francais Du Fractionnement "ensemble de moyens pour le traitement d'une pathologie maligne, d'une maladie auto-immune ou d'une maladie infectieuse"
JP2010220479A (ja) * 2007-06-15 2010-10-07 Medeinetto:Kk Ｎｋ細胞の培養方法及びｎｋ細胞の利用
SG11201608192SA (en) * 2014-04-11 2016-10-28 Medimmune Llc Bispecific her2 antibodies
US20180244787A1 (en) * 2016-12-22 2018-08-30 Sanofi Anti-human cxcr3 antibodies for treatment of vitiligo
US11753619B2 (en) * 2017-02-02 2023-09-12 The Scripps Research Institute Engineered cells and methods of use

Similar Documents

Publication Publication Date Title
US11993663B2 (en) Low-viscosity antigen binding proteins and methods of making them
US12195529B2 (en) Heterodimeric bispecific antibodies
KR102524594B1 (ko) 시스테인 프로테아제
KR102524613B1 (ko) 시스테인 프로테아제
JP2017522384A5 (https=)
JP2021529531A5 (https=)
JP7770341B2 (ja) システインプロテアーゼ
JP2022191210A5 (https=)
JP2024532726A5 (https=)
JP2023535842A5 (https=)
JP2024508886A5 (https=)
US10745463B2 (en) Hyper-glycosylated antibodies with selective Fc receptor binding
WO2024220732A1 (en) Endoglycosidase s2 (endos2) mutants and uses thereof
US20190161759A1 (en) Amplified production of monoclonal antibodies
NZ743923B2 (en) Chimeric proteins and methods of immunotherapy
NZ743923A (en) Chimeric proteins and methods of immunotherapy
EA043899B1 (ru) Антигенсвязывающие белки, характеризующиеся низкой вязкостью, и способы их получения
CN104955479A (zh) 高温死端抗体过滤